|
|
Volumn 12, Issue 11, 2015, Pages 622-
|
|
Immunotherapy: Evading immune escape: Synergy of COX and immune-checkpoint inhibitors
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2;
IMMUNE CHECKPOINT INHIBITOR;
IMMUNOLOGIC AGENT;
PROSTAGLANDIN E2;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER IMMUNOTHERAPY;
CELL FUNCTION;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
IMMUNOCOMPETENT CELL;
IMMUNOMODULATION;
INNATE IMMUNITY;
MALIGNANT NEOPLASTIC DISEASE;
NOTE;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS;
PROTEIN EXPRESSION;
TUMOR ESCAPE;
TUMOR IMMUNITY;
ANIMAL;
IMMUNOLOGY;
METABOLISM;
NEOPLASM;
ANIMALS;
HUMANS;
NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
TUMOR ESCAPE;
|
|
EID: 84946479842
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2015.167 Document Type: Note |
|
Times cited : (10)
|
|
References (1)
|
